Certain Nasal Bacteria May Boost COVID-19 Risk
Nasal bacteria can affect the levels of key proteins the SARS-CoV-2 virus needs to enter human cells and may explain why some individuals are more susceptible to COVID-19 infection.
Nasal bacteria can affect the levels of key proteins the SARS-CoV-2 virus needs to enter human cells and may explain why some individuals are more susceptible to COVID-19 infection.
Nasal bacteria can affect the levels of key proteins the SARS-CoV-2 virus needs to enter human cells and may explain why some individuals are more susceptible to COVID-19 infection.
Read MoreOvershadowed by the current measles epidemic is the fact that whooping cough cases are rising due to drops in vaccination rates.
Read MoreA second school-aged child has died of measles infection in Texas, the third fatality nationwide in 2025.
Read MoreScientists are developing sensor-based tests to quickly detect superbugs like K. pneumoniae, S. aureus, and P. aeruginosa.
Read MoreA recent CDC statement may signal a shift in the agency’s longstanding practice of advocating vaccinations for infectious diseases like measles.
Read MoreThe actor best known for his roles in Top Gun, Tombstone, Heat, Batman Forever, and The Doors, passed away Tuesday at the age of 65 due to pneumonia.
Read MoreThe Louisiana Surgeon General’s Office is reporting two infant deaths as a result of pertussis (whooping cough) “within the last six months.”
Read MoreThe ECRI’s annual list of patient safety threats includes healthcare-associated infections and medical misinformation, but it’s topped by a particular physician behavior towards patients and caregivers that can lead to a loss of trust.
Read MoreAn unidentified respiratory virus is suspected to be the sole cause of Kawasaki disease, a rare condition that typically affects children under five-years-old.
Read MorePatients hospitalized for respiratory infections or sepsis had more than double the odds of heart failure later in life.
Read MoreThe CDC says a total of 800 confirmed measles cases have been reported by 27 states, driven by outbreaks in nine states — most notably Texas, which now has 597 cases.
Read MoreThe Study of Tecovirimat for Mpox (STOMP) began in September 2022 as part of the US whole-of-government response to the clade II mpox outbreak.
Read MoreThe New Mexico Department of Health is reporting 30 infections, while one international traveler in Maryland was confirmed positive.
Read MoreA copper-impregnated surface significantly reduced C. difficile spores by over 97% within four hours, offering continuous antimicrobial protection.
Read MoreThe Texas measles outbreak has grown to 597 cases, as of Apr 18, 2025, a 10% increase since last week.
Read MoreA school-aged child has died in Texas after being hospitalized for measles, the first death in the current West Texas outbreak and first US death from the virus since 2015.
Read MoreEveryday smartwatches are extremely accurate in detecting viral infection long before symptoms appear — now, research shows how they could help stop a pandemic before it even begins.
Read MorePope Francis, who was recovering from a 38-day hospitalization for bronchitis and bilateral pneumonia, died early Monday morning at the Vatican. He was 88.
Read MoreLive bird markets in New York City and surrounding counties have been shut down with the discovery of the H5N1 bird flu virus.
Read MoreThe Trump administration has paused the release of CDC studies on bird flu, delaying research on potential human infections and animal transmission, a KFF report finds.
Read MoreA tuberculosis outbreak that has infected 67 people in the greater Kansas City metro area is the largest in US history, according to Kansas Dept of Health and Environment.
Read MoreThe latest clinical practice guidelines advocate for four- and six-month all-oral regimens for eligible children and adults with drug-susceptible or drug-resistant tuberculosis.
Read MoreNearly one-third of respondents aren’t sure if whooping cough and pertussis are the same illness, and 30% are uncertain whether a vaccine exists.
Read MoreA clinical trial testing a smallpox antiviral for mpox was halted after interim findings showed no efficacy in reducing lesion resolution or pain in mild to moderate cases.
Read More